Investment Summary |
|
|---|---|
| Date | 2017-10-24 |
| Target | Y-mAbs Therapeutics |
| Sector | Life Science |
| Investor(s) | HBM Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 2.1B USD |
| Size | Large |
| Type | Sector Focused |
HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 65 |
| Sector: Life Science M&A | 13 of 56 |
| Type: Venture M&A Deals | 11 of 52 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 12 of 44 |
| Year: 2017 M&A | 5 of 6 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-10-06 |
Harmony
Plymouth Meeting, Pennsylvania, United States Harmony is a biopharmaceutical company developing and commercializing innovative drugs to address unmet needs for patients with sleep and CNS disorders. Harmony was founded in 2017 and is based in Plymouth Meeting, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-11-02 |
Allena Pharmaceuticals
Newton, Massachusetts, United States Allena Pharmaceuticals is a clinical biopharma company developing first-in-class, oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena Pharmaceuticals was founded in 2011 and is based in Newton, Massachussetts. |
Sell | - |
